Dalian Bio-Chem Co Ltd

SHG:603360 China Specialty Chemicals
Market Cap
$2.52 Billion
CN¥18.52 Billion CNY
Market Cap Rank
#7414 Global
#1258 in China
Share Price
CN¥26.23
Change (1 day)
-2.16%
52-Week Range
CN¥19.38 - CN¥38.13
All Time High
CN¥244.62
About

Dalian BIO-CHEM Company Limited researches, develops, produces, and sells industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is headquartered in Dalian, China.

Dalian Bio-Chem Co Ltd (603360) - Net Assets

Latest net assets as of September 2025: CN¥2.08 Billion CNY

Based on the latest financial reports, Dalian Bio-Chem Co Ltd (603360) has net assets worth CN¥2.08 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.66 Billion) and total liabilities (CN¥1.58 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥2.08 Billion
% of Total Assets 56.85%
Annual Growth Rate 21.68%
5-Year Change 137.91%
10-Year Change 552.8%
Growth Volatility 14.86

Dalian Bio-Chem Co Ltd - Net Assets Trend (2011–2024)

This chart illustrates how Dalian Bio-Chem Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Dalian Bio-Chem Co Ltd (2011–2024)

The table below shows the annual net assets of Dalian Bio-Chem Co Ltd from 2011 to 2024.

Year Net Assets Change
2024-12-31 CN¥2.35 Billion +43.65%
2023-12-31 CN¥1.64 Billion +12.01%
2022-12-31 CN¥1.46 Billion +39.21%
2021-12-31 CN¥1.05 Billion +6.21%
2020-12-31 CN¥988.28 Million -4.37%
2019-12-31 CN¥1.03 Billion +29.50%
2018-12-31 CN¥798.03 Million +16.26%
2017-12-31 CN¥686.42 Million +49.84%
2016-12-31 CN¥458.09 Million +27.19%
2015-12-31 CN¥360.17 Million +18.81%
2014-12-31 CN¥303.16 Million +9.39%
2013-12-31 CN¥277.14 Million +21.44%
2012-12-31 CN¥228.22 Million +24.43%
2011-12-31 CN¥183.41 Million --

Equity Component Analysis

This analysis shows how different components contribute to Dalian Bio-Chem Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 3331.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.00 Billion 56.00%
Common Stock CN¥504.45 Million 28.21%
Other Components CN¥282.50 Million 15.80%
Total Equity CN¥1.79 Billion 100.00%

Dalian Bio-Chem Co Ltd Competitors by Market Cap

The table below lists competitors of Dalian Bio-Chem Co Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Dalian Bio-Chem Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,636,719,076 to 1,788,474,436, a change of 151,755,360 (9.3%).
  • Net income of 345,256,432 contributed positively to equity growth.
  • Dividend payments of 223,623,814 reduced retained earnings.
  • Other factors increased equity by 30,122,742.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥345.26 Million +19.3%
Dividends Paid CN¥223.62 Million -12.5%
Other Changes CN¥30.12 Million +1.68%
Total Change CN¥- 9.27%

Book Value vs Market Value Analysis

This analysis compares Dalian Bio-Chem Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 7.45x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 35.75x to 7.45x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2011-12-31 CN¥0.73 CN¥26.23 x
2012-12-31 CN¥0.84 CN¥26.23 x
2013-12-31 CN¥1.01 CN¥26.23 x
2014-12-31 CN¥1.10 CN¥26.23 x
2015-12-31 CN¥1.31 CN¥26.23 x
2016-12-31 CN¥1.67 CN¥26.23 x
2017-12-31 CN¥1.96 CN¥26.23 x
2018-12-31 CN¥2.19 CN¥26.23 x
2019-12-31 CN¥2.82 CN¥26.23 x
2020-12-31 CN¥2.71 CN¥26.23 x
2021-12-31 CN¥2.96 CN¥26.23 x
2022-12-31 CN¥4.36 CN¥26.23 x
2023-12-31 CN¥4.64 CN¥26.23 x
2024-12-31 CN¥3.52 CN¥26.23 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Dalian Bio-Chem Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 19.30%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 26.32%
  • • Asset Turnover: 0.36x
  • • Equity Multiplier: 2.04x
  • Recent ROE (19.30%) is below the historical average (21.02%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 22.85% 20.09% 0.45x 2.50x CN¥23.57 Million
2012 19.63% 17.47% 0.52x 2.16x CN¥21.99 Million
2013 17.65% 16.79% 0.53x 1.97x CN¥21.21 Million
2014 21.12% 18.47% 0.61x 1.86x CN¥33.72 Million
2015 15.90% 17.48% 0.60x 1.52x CN¥21.28 Million
2016 21.42% 25.23% 0.62x 1.36x CN¥52.38 Million
2017 14.58% 24.43% 0.53x 1.13x CN¥31.51 Million
2018 18.16% 27.49% 0.59x 1.12x CN¥65.25 Million
2019 29.69% 35.19% 0.73x 1.15x CN¥203.45 Million
2020 22.44% 29.59% 0.52x 1.45x CN¥122.93 Million
2021 23.86% 24.89% 0.60x 1.59x CN¥145.53 Million
2022 27.55% 32.03% 0.72x 1.20x CN¥256.44 Million
2023 20.06% 30.81% 0.55x 1.19x CN¥164.70 Million
2024 19.30% 26.32% 0.36x 2.04x CN¥166.41 Million

Industry Comparison

This section compares Dalian Bio-Chem Co Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $1,775,158,628
  • Average return on equity (ROE) among peers: -19.15%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Dalian Bio-Chem Co Ltd (603360) CN¥2.08 Billion 22.85% 0.76x $978.80 Million
Chongqing Sanxia Paints Co Ltd (000565) $390.80 Million 1.64% 0.47x $289.82 Million
Hengyi Petrochemical Co Ltd (000703) $246.42 Million -7.64% 1.62x $1.44 Billion
Guangdong Xinhui Meida Nylon Co Ltd (000782) $472.56 Million 10.49% 1.13x $361.89 Million
Luxi Chemical Group Co Ltd (000830) $120.60 Million 41.32% 1.30x $2.28 Billion
China Minmetals Rare Earth Co Ltd (000831) $234.51 Million -303.65% 8.65x $5.40 Billion
Anhui Guofeng Plastic Industry Co Ltd (000859) $2.70 Billion 10.47% 0.21x $884.45 Million
Cofco Biochemical Anhui Co Ltd (000930) $11.76 Billion 9.61% 0.54x $815.97 Million
Shandong Link Science and Technology Co Ltd (001207) $441.43 Million 14.99% 1.14x $330.19 Million
Zhejiang Bofay Elec Co Ltd (001255) $742.80 Million 1.78% 0.61x $169.49 Million
Guangdong Decro Film New (001378) $647.89 Million 29.53% 0.22x $241.78 Million